Literature DB >> 7286561

Fecal bile acid analysis in healthy Japanese subjects using a lipophilic anion exchanger, capillary column gas chromatography and mass spectrometry.

N Tanida, Y Hikasa, M Hosomi, M Satomi, I Oohama, T Shimoyama.   

Abstract

Detailed fecal bile acid profiles of healthy Japanese subjects were studied using a lipophilic anion exchanger, capillary gas chromatography and mass spectrometry. Total dairy excretion of bile acid into feces corrected for by fecal markers were between 127.99 to 366.33 mumole per day. Unconjugated bile acids constituted a major part, between 80 and 96%, of fecal bile acids. Glycine conjugated, taurine conjugated and sulfated bile acids were between 1 to 6, 0 to 3 and 1 to 10%, respectively. Esterified bile acids at C-24 position existed between 1 to 5%. Primary bile acids ranged from 0 to 55%. There were a number of epimers of hydroxy- and keto-bile acids, and lithocholic and deoxycholic acid were major secondary bile acids among them. A cholenoic acid was detected in the unconjugated fraction of one subject. It seems necessary to analyze the details not only on the type of bile acids but also on the mode of conjugation in biological samples. Thus, the methodology described in this study has made it easier to investigate on the role of bile acid in the physiology or pathophysiology of the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286561     DOI: 10.1007/BF02774469

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  19 in total

1.  Fecal steroids and bacterial flora in patients with polyposis coli.

Authors:  A L Watne; H Y Lai; T Mance; S Core
Journal:  Am J Surg       Date:  1976-01       Impact factor: 2.565

2.  Bile acids: co-mutagenic activity in the Salmonella-mammalian-microsome mutagenicity test: brief communication.

Authors:  S J Silverman; A W Andrews
Journal:  J Natl Cancer Inst       Date:  1977-11       Impact factor: 13.506

3.  Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps.

Authors:  B S Reddy; E L Wynder
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

4.  Diet, fecal bile acids, and neutral sterols in carcinoma of the colon.

Authors:  M Moskovitz; C White; R N Barnett; S Stevens; E Russell; D Vargo; M H Floch
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

5.  Bacteria and the aetiology of cancer of the large bowel.

Authors:  V Aries; J S Crowther; B S Drasar; M J Hill; R E Williams
Journal:  Gut       Date:  1969-05       Impact factor: 23.059

6.  Bacteria and aetiology of cancer of large bowel.

Authors:  M J Hill; B S Drasar; G Hawksworth; V Aries; J S Crowther; R E Williams
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

7.  The enzymatic cleavage of the carbon-nitrogen bond in 3-alpha, 7-alpha, 12-alpha-trihydroxy-5-beta-cholan-24-oylglycine.

Authors:  P P Nair; M Gordon; J Reback
Journal:  J Biol Chem       Date:  1967-01-10       Impact factor: 5.157

8.  Isolation and purification of lithocholic acid metabolites produced by the intestinal microflora.

Authors:  M I Kelsey; S A Sexton
Journal:  J Chromatogr       Date:  1977-03-21

9.  Determination of bile acids in serum by capillary gas-liquid chromatography.

Authors:  G Karlaganis; G Paumgartner
Journal:  Clin Chim Acta       Date:  1979-02-15       Impact factor: 3.786

10.  Faecal bile-acids and clostridia in patients with cancer of the large bowel.

Authors:  M J Hill; B S Drasar; R E Williams; T W Meade; A G Cox; J E Simpson; B C Morson
Journal:  Lancet       Date:  1975-03-08       Impact factor: 79.321

View more
  8 in total

1.  Effects of 5 beta-chol-3-en-24-oic acid, and lithocholic acid and its sulfates on prostaglandin E2 output in perfusion of the rat colon.

Authors:  Y Hikasa; N Tanida; K Sawada; K Furukawa; M Kano; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1989-02

2.  High concentration and retained amidation of fecal bile acids in patients with active ulcerative colitis.

Authors:  N Tanida; Y Hikasa; M Dodo; K Sawada; A Kawaura; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1986-06

3.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

4.  Comparison of faecal bile acid profiles between patients with adenomatous polyps of the large bowel and healthy subjects in Japan.

Authors:  N Tanida; Y Hikasa; T Shimoyama; K D Setchell
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

5.  Faecal bile acid profiles in patients with large bowel cancer in Japan.

Authors:  Y Hikasa; N Tanida; T Ohno; T Shimoyama
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

6.  Formation of delta 2- and delta 3-cholenoic acids from bile acid 3-sulfates by a human intestinal Fusobacterium strain.

Authors:  J Robben; G Janssen; R Merckx; H Eyssen
Journal:  Appl Environ Microbiol       Date:  1989-11       Impact factor: 4.792

7.  Partial purification and characterization of an NAD-dependent 3 beta-hydroxysteroid dehydrogenase from Clostridium innocuum.

Authors:  R Edenharder; M Pfützner
Journal:  Appl Environ Microbiol       Date:  1989-06       Impact factor: 4.792

8.  Fecal bile acid excretion pattern in colonic cancer patients.

Authors:  N F Breuer; P Dommes; S Jaekel; H Goebell
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.